PFBT
RYTM icon

Parkside Financial Bank & Trust’s Rhythm Pharmaceuticals RYTM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.66K Hold
33
– – ﹤0.01% 1995
2026
Q1 		$2.87K Hold
33
– – ﹤0.01% 1996
2025
Q4 		$3.53K Hold
33
– – ﹤0.01% 1905
2025
Q3 		$3.33K Hold
33
– – ﹤0.01% 1851
2025
Q2 		$2.09K Buy
33
+13
+65% +$796 ﹤0.01% 1989
2025
Q1 		$1.06K Buy
+20
New +$1.11K ﹤0.01% 2085

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Parkside Financial Bank & Trust's RYTM Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 33 shares worth $3.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1995.

Parkside Financial Bank & Trust first reported a position in RYTM in Q1 2025 and has held it in 6 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Parkside Financial Bank & Trust held 33 shares of Rhythm Pharmaceuticals worth $3.66K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1995 holding.
  • Parkside Financial Bank & Trust first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.